Table 5.
Quartile for serum iron | P-trend | ||||
---|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | ||
NAFLD | |||||
Males | |||||
Cases/N | 2577/4815 | 2295/4545 | 2062/4264 | 1874/4407 | |
Model 1 | 1.00 (Ref.) | 0.86 (0.77–0.97) | 0.78 (0.70–0.88) | 0.67 (0.60–0.75) | < 0.001 |
Model 2 | 1.00 (Ref.) | 0.89 (0.79–0.99) | 0.80 (0.71–0.90) | 0.69 (0.62–0.78) | < 0.001 |
Model 3 | 1.00 (Ref.) | 0.89 (0.79–1.00) | 0.81 (0.72–0.91) | 0.70 (0.63–0.79) | < 0.001 |
Females | |||||
Cases/N | 2471/5122 | 2128/4887 | 1735/4711 | 1130/4269 | |
Model 1 | 1.00 (Ref.) | 0.77 (0.69–0.86) | 0.55 (0.50–0.62) | 0.36 (0.32–0.41) | < 0.001 |
Model 2 | 1.00 (Ref.) | 0.78 (0.69–0.87) | 0.58 (0.51–0.65) | 0.39 (0.34–0.45) | < 0.001 |
Model 3 | 1.00 (Ref.) | 0.78 (0.69–0.87) | 0.58 (0.51–0.65) | 0.39 (0.34–0.45) | < 0.001 |
AHF | |||||
Males | |||||
Cases/N | 237/4796 | 179/4522 | 131/4235 | 99/4382 | |
Model 1 | 1.00 (Ref.) | 0.88 (0.64–1.20) | 0.76 (0.55–1.06) | 0.63 (0.44–0.90) | 0.006 |
Model 2 | 1.00 (Ref.) | 0.92 (0.67–1.26) | 0.80 (0.57–1.12) | 0.70 (0.49–1.01) | 0.031 |
Model 3 | 1.00 (Ref.) | 0.92 (0.66–1.26) | 0.79 (0.56–1.12) | 0.72 (0.50–1.04) | 0.046 |
Females | |||||
Cases/N | 202/5102 | 198/4869 | 157/4690 | 83/4252 | |
Model 1 | 1.00 (Ref.) | 0.80 (0.58–1.10) | 0.64 (0.46–0.89) | 0.52 (0.35–0.79) | < 0.001 |
Model 2 | 1.00 (Ref.) | 0.82 (0.59–1.13) | 0.70 (0.50–0.98) | 0.64 (0.42–0.96) | 0.015 |
Model 3 | 1.00 (Ref.) | 0.81 (0.59–1.12) | 0.70 (0.50–0.98) | 0.64 (0.43–0.97) | 0.018 |
Model 1: age (years), race (Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, other race), marital status (married or cohabitation, widowed or separated, never married), education level (less than 12th grade, high school or equivalent, college graduate or above), family poverty income ratio; Model 2: model 1 + smoking status (never, ever, current), alcohol intake (drinkers/week), leisure activity (MET-min/day), total energy intake (kcal/day), healthy eating index-2015; Model 3: model 2 + lead (μg/dL), cadmium (nmol/L).
AHF advanced hepatic fibrosis, MET metabolic equivalent, NAFLD non-alcohol fatty liver disease.